Hong Kong vs Israel: HIV-positive TB patients on ART (antiretroviral therapy)
Hong Kong
100.0%
in 2024
Israel
100.0%
in 2024
Hong Kong rank
1st
Israel rank
1st
HIV-positive TB patients on ART (antiretroviral therapy) over time
- Hong Kong
- Israel
How they compare
Hong Kong currently reports 100.0% against 100.0% in Israel, a difference of 0.0%.
The two have swapped places 2 times across 12 shared years of data; in 2008 it was Israel ahead.
Hong Kong ranks 1st and Israel ranks 1st of 144 countries.
Israel has averaged higher in every one of the 3 decades both report.
Head to head by decade
| Decade | Hong Kong | Israel | Difference | Ahead |
|---|---|---|---|---|
| 2000s | 29.5% | 68.0% | 38.5% | Israel |
| 2010s | 31.5% | 100.0% | 68.5% | Israel |
| 2020s | 92.2% | 98.2% | 6.0% | Israel |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher hiv-positive tb patients on art (antiretroviral therapy), Hong Kong or Israel?
- Hong Kong, at 100.0% against 100.0% in Israel as of 2024.
- What is the difference in hiv-positive tb patients on art (antiretroviral therapy) between Hong Kong and Israel?
- 0.0%, with Hong Kong ahead.
- How many years of comparable data are there for Hong Kong and Israel?
- 12 years are reported by both, from 2008 to 2024.
- How do Hong Kong and Israel rank globally for hiv-positive tb patients on art (antiretroviral therapy)?
- Hong Kong ranks 1st and Israel ranks 1st of 144 countries.
- Where does this data come from?
- World Health Organization, Global Health Observatory, published as HIV-positive TB patients on ART (antiretroviral therapy) (%). Statizoid refreshes it automatically from the source and publishes the full history for both places.